Past Announcements

From: Yvonne Janssen-Heininger, Ph.D.: What are the latest discoveries in the study of Oxygen Radicals? Join me in Ventura, CA next February and find out!

My co-chair, Manisha Patel PhD, and I have put together a Gordon Research Conference: “OXYGEN RADICALS – CHEMICAL REACTIVITY, METABOLISM, & OPPORTUNITIES FOR THERAPEUTIC DEVELOPMENT.”

GRC poster oxygen radical 2019

See poster here

It’s going to be an exciting program with a diverse range of outstanding speakers, both junior and senior. Discussions will emphasize both opportunities and obstacles in developing redox-based compounds for therapeutics. Our goal is to spread knowledge and foster new collaborations leading to future discoveries!

The conference will be from Feb. 2nd to 7th. For more information, go to https://www.grc.org/oxygen-radicals-conference/2020/.

____________________________

Recently accepted review by Wyatt Chia of the Janssen-Heininger lab was recognized by AJP-CellBio with an “Image of the Week”. 

https://twitter.com/AJPCellPhys   

https://www.facebook.com/AJPCellPhys/

____________________________

Arti%20Award%202Dr. Arti Shukla, Ph.D. awarded prestigious award: She was invited by OHSU Knight Cancer Institute (Portland, Oregon) to deliver Michael J.  Hasson Lectureship for Mesothelioma on Monday, Oct 7 and was presented with an award, recognizing her outstanding work in mesothelioma research. 

 

 

 

_________________

Dr. Jos van der Velden was featured in the 2019 summer edition of  Vermont Medicine.

_____________________

Dr. Brian Cunniff's research was the focus of a recent commentary in mSphere, a journal published by The American Society for Microbiology. Congratulations Brian ! Read the commentary

______________________

AlbertvanderVliet

Dr. Albert van der Vliet, Ph.D. has been asked to join the Editorial Board of Scientific Reports, an online open access journal from the publishers of Nature. Board members manage the peer review process for manuscripts submitted to the journal.

____________________

Dr. Albert van der Vliet, Ph.D. will be a symposium speaker at an upcoming annual meeting of the Japanese Respiratory Society (April 12-14 in Tokyo), where he will be discussing the current status of oxidative stress in COPD and implications for therapeutic approaches.

____________________

Phil_MunsonPhillip Munson, a graduate student in Arti Shukla’s lab was recently invited to present his research to Dean Richard Page and the Medical Alumni Executive Committee. Thanks for representing UVM CMB graduate students!

Additionally, Phillip Munson will be presenting at the American Association for Cancer Research Meeting on April 1, 2019 in Atlanta Georgia. The title of his talk is “Exosomes in Mesothelioma. Congrats Phillip!

 

________________________

Janssen-HeiningerDr. Yvonne Jenssen-Heininger, Ph.D. will present a University Scholar Lecture: Using the Domain of Redox Biology to Understand Chronic Lung Diseases and to Provide Avenues for Drug Development, Wednesday, March 20th, 4:00 pm in the Waterman Memorial Lounge.

 

 

___________________________

BrianCunniff

Dr. Brian Cunniff, Ph.D. received a UVM Cancer Center Pilot award entitled ”Mitochondrial positioning determines subcellular redox modifications supporting cell migration and metastasis.” Dr. Albert van der Vliet, Ph.D. will also serve as a Co-PI on the project. Congratulations to Drs. Cunniff and van der Vliet!

 

 

heintzDr. Nick Heintz, Ph.D. received the 2018 UVM Medical Alumni Association’s Distinguished Graduate Alumni Award​, which is presented to Larner College of Medicine (LCOM) alumni who have demonstrated outstanding achievement in basic, clinical or applied research; education; industry; public service/humanitarianism; and/or outstanding commitment to the LCOM community. He accepted his award at the college's Celebrating Research Excellence event at the end of October. (September 2018)

 

Janssen_Heininger_VCCDr. Yvonne Janssen-Heininger, Ph.D. to be inducted as a University Scholar...read here. (3/2018)

Dr. Yvonne Janssen-Heininger, Ph. D. was awarded a patent on the ​concept that strategies to inhibit GSTP has utility for the treatment of patients with pulmonary fibrosis. Congratulations, Yvonne! (Jan. 2018)